The largest database of trusted experimental protocols

Pcmv6 ac ha vector

Manufactured by OriGene
Sourced in United States

The PCMV6-AC-HA vector is a plasmid used for the expression of proteins with a hemagglutinin (HA) tag in mammalian cells. The vector contains the cytomegalovirus (CMV) promoter for high-level expression of the target protein, as well as the HA tag sequence for detection and purification purposes.

Automatically generated - may contain errors

3 protocols using pcmv6 ac ha vector

1

Engineered MICU1 Plasmid Construction

Check if the same lab product or an alternative is used in the 5 most similar protocols
To generate the BioID2-HA plasmid, BioID2 was PCR-amplified from the MCS-BioID2-HA plasmid (Addgene #74224) using primers designed to introduce an ATG start codon immediately downstream of the BamHI restriction site of the MCS. The PCR product was cut by BamHI and HindIII and cloned into the MCS-BioID2-HA plasmid (Addgene #74224). To generate the MICU1-BioID2-HA, MICU1 was PCR amplified from the hMICU1-Myc-DDK plasmid using primers to introduce a 5’ AgeI and a 3’ BamHI restriction site. The PCR product was cut by AgeI and BamHI and cloned into the MCS-BioID2-HA plasmid (Addgene #74224). The MICU1-HA plasmid was generated by cleaving the MICU1 fragment from the MICU1-FLAG plasmid (Origene # MR207652) using the SgfI-MluI restriction sites and inserted into the same sites in pCMV6-AC-HA vector (Origene # PS100004). Flag-tagged Mouse MICU1 (NM_144822) mutants; EMREmut KKKKR101-105QQQQQ; EF1mut D233A, E244A; EF2mut D423A, E434A; EF1/2mut D233A, E244A, D423A, E434A; MCUmut K440A, R442A, R445A; mtCUmut KKKKR101-105QQQQQ, K440A, R442A, R445A; Dimermut C465A; Truncation 1 (T1): Δ60 – 134; Truncation 2 (T2): Δ135 – 220; Truncation 3 (T3): Δ221 – 314; Truncation 4 (T4): Δ315 – 399; Truncation 5 (T5): Δ400 – 477 were custom cloned by Vector Builder Inc. Plasmids were confirmed by restriction digestion and DNA sequencing. Specific details of plasmid sources are provided in table S1.
+ Open protocol
+ Expand
2

Generating Stable Cell Lines Expressing Proteins

Check if the same lab product or an alternative is used in the 5 most similar protocols
MYC-tagged SPHK1 was created in the pCMV6-AN-MYC (PS100012, Origene) vector by standard subcloning. CDH1 was constructed in the pCMV6 vector (PS100001, Origene) by standard subcloning. HA-tagged BECN1 was constructed in the pCMV6-AC-HA vector (PS100004, Origene) by standard subcloning. Flag-tagged TRAF2 and its mutant (ΔRING) were cloned into the pFLAG-CMV-2 expression plasmid (E7033, Sigma).
Human liver carcinoma HepG2 cells were purchased from American Type Culture Collection (ATCC, HB-8065) and maintained according to their instructions. Transient transfection was performed using Lipofectamine 2000 (Invitrogen, 11668019) or Lipofectamine RNAiMax (Invitrogen, 13778150) according to the manufacturer's instructions. To generate HepG2 cells stably expressing SPHK1, the pCMV6-AN-MYC and the MYC-tagged SPHK1 plasmids were both transfected into HepG2 cells. After 24 h of transfection, stable transfectants were selected using neomycin, and a single clone was amplified using a dilution-cloning technique.
+ Open protocol
+ Expand
3

Overexpression of GRβ in Dysplastic HBMECs

Check if the same lab product or an alternative is used in the 5 most similar protocols
To simulate the increase in GRβ expression observed in the dysplastic tissue compared to non-dysplastic, HBMECs were transfected with HA-tagged GRβ DNA (1.075 µg/µL). The custom HA-tagged GRβ plasmid was obtained from OriGene Technologies utilizing the open reading frame (ORF) from cat. RC220377 (OriGene Technologies, Rockville, MD, USA) cloned in a pCMV6-AC-HA vector (OriGene Technologies, cat. PS100004). To achieve this transfection, 5 µg of HA-GRβ DNA was mixed in serum-free Dulbecco’s modified eagle medium (DMEM/F12) and was later combined with a 30 µg mixture of lipofectamine (Thermo Fisher Scientific, cat. 18324-012) in serum-free DMEM to form the DNA+lipofectamine complex. This mixture was set aside for 25 min at room temperature. Once formed, this DNA+lipofectamine complex was combined with additional serum-free DMEM and added to the 100 mm Petri dish of 70% confluent HBMECs and left to incubate for 5 h at 37 °C. After the incubation was complete, the serum-free media containing the DNA+lipofectamine complex was aspirated, the plate was washed with 0.1 M phosphate-buffered saline (PBS), and the PBS was replaced with normal HBMEC media (Cell Systems, cat. 4Z0-500) until the following day when subsequent drug treatment experiments were performed. These transfected cells will be denoted throughout as “HBMEC+HA-GRβ”.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!